# NNB Nutrition

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nnb-nutrition

- Industry: Biotechnology
- Headquarters: Nanjing, China
- Website: www.nnbnutritionchina.com/
- Latest round: Series C (Mar 16, 2026)
- Investors on record: 4

## About

Founded in 2015 in Nanjing, China, Nanjing Nutrabuilding Bio-Tech Co.,Ltd., trading as NNB Nutrition, focuses on creating innovative dietary supplement ingredients.The company has several branches, including Nanjing Aixidi Biotechnology Co., Ltd., Chuzhou Newbon Biotechnology Co., Ltd., Anhui Newjian Biotechnology Co., Ltd., etc. It has design, clinical development and marketing subsidiaries in Dallas and San Francisco, USA. In July 2026, NNB Nutrition raised nearly CNY 200 million in series C+ funding led by China Life Capital, with participation from Mingxi Capital.

NNB Nutrition specializes in the development and production of innovative dietary supplement ingredients. Its product pipeline covers areas such as weight loss, muscle building, sugar control, and anti-aging. Niubang markets its products globally, serving clients in North America, Europe, and Asia.

The company’s revenue is generated by providing raw materials, semi-finished products and finished products for dietary supplements.

The company will use the latest funding for product research and development, and the construction of a new factory.

## Funding rounds

- Series C, Mar 16, 2026 — Hubei Science Technology Investment Group, Addor Capital, ALAN AMC, Mingxi Capital
- Series B, Jan 7, 2026 — Mingxi Capital
- Series B, Dec 30, 2024 — ALAN AMC
- Series A, Nov 4, 2021 — Addor Capital

## Investors

- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series A, Series C
- ALAN AMC (https://capitalatlas.ai/funds/alan-amc) — Series B, Series C
- Mingxi Capital (https://capitalatlas.ai/funds/mingxi-capital) — Series B, Series C
- Hubei Science Technology Investment Group — Series C